Dysregulated Tyrosine Kinase Signaling in Leukemia

Terminated

• Conditions: Leukemia

• Registration Number: NCT00277056
• Lead Sponsor: University of New Mexico

Brief Summary

Dysregulated Tyrosine Kinase Signaling in Leukemia

Detailed Description

Purpose: to look at a number of proteins in the abnormal cells in the blood and/or bone marrow. These proteins make a cell grow or prevent the cell from dying

Study Timeline

• Study Start: 2002-05
• Primary Completion: 2005-10
• Study Completion: 2005-10
• Study First Submitted: 2006-01-11
• Study First Submitted QC: 2006-01-11
• Study First Posted: 2006-01-13
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-05
• Last Update Posted: 2024-02-07

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients must have newly diagnosed or relapsed leukemia.
• Patients must sign an informed consent.
• Patients will not be excluded if they are receiving chemotherapy.
• Patients with CML, AML, ALL, T/NK leukemia, myelodysplasia, or myeloproliferative disorders will be eligible.
• Patients must be => 18 years of age.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

University of New Mexico; 🇺🇸 Albuquerque, New Mexico, United States